Prothya Biosolutions Revenue and Competitors

Amsterdam, Netherlands

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Prothya Biosolutions's estimated annual revenue is currently $75M per year.(i)
  • Prothya Biosolutions's estimated revenue per employee is $201,000

Employee Data

  • Prothya Biosolutions has 373 Employees.(i)
  • Prothya Biosolutions grew their employee count by -8% last year.

Prothya Biosolutions's People

NameTitleEmail/Phone
1
Senior QA OfficerReveal Email/Phone
2
Regulatory Affairs OfficerReveal Email/Phone
3
Senior Quality Assurance OfficerReveal Email/Phone
4
QA Operations OfficerReveal Email/Phone
5
Senior Quality Assurance OfficerReveal Email/Phone
6
Global Marketing ManagerReveal Email/Phone
7
QC ManagerReveal Email/Phone
8
Production ManagerReveal Email/Phone
9
Bioprocess TechnicianReveal Email/Phone
10
Site Automation LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.9M69-1%N/AN/A
#2
$43.8M218-13%N/AN/A
#3
$51.9M2584%N/AN/A
#4
$32.2M1600%N/AN/A
#5
$237.8M1183-1%N/AN/A
#6
$3.8M1946%N/AN/A
#7
$237.8M1183-1%N/AN/A
#8
$20.1M100-31%N/AN/A
#9
$75M373-8%N/AN/A
#10
$2M1025%N/AN/A
Add Company

What Is Prothya Biosolutions?

Prothya Biosolutions produces plasma-derived medicines under its own brand name, including Cofact, Nanogam and Albuman. In addition, the company is commissioned to obtain and process blood plasma for bio-pharmaceutical companies around the world. Prothya Biosolutions’ mission is to provide healthcare-oriented organizations worldwide with high-quality plasma products. The company is creating value for partners and is contributing to the health of people who depend on essential plasma proteins. That’s why Prothya Biosolutions’ slogan is: Creating Value, Sustaining Life. The company has several offices and production locations in the Netherlands and Belgium, and collectively employs about 1,000 people.

keywords:N/A

N/A

Total Funding

373

Number of Employees

$75M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Prothya Biosolutions News

2022-04-06 - The Global Plasma Therapeutics Market is expected to grow by $ 8.98 bn during 2022-2026 progressing at a CAGR of 6.1% during the forecast period

... Kedrion Spa, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd., and Takeda Pharmaceutical Co.

2022-03-22 - Bloedplasma van Nederlandse donoren helpt gewonde Oekraïners

De verzending is gedaan door het gespecialiseerde bedrijf Prothya Biosolutions. Die onderneming produceert geneesmiddelen met plasma dat is...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M373-8%N/A
#2
$84.2M3744%N/A
#3
$98.7M376-40%N/A
#4
$96.6M3772%N/A
#5
$69.6M3845%N/A